Flu Shot's hidden clues: blood tests may reveal new health insights
NCT ID NCT07604103
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study measures three blood markers (GDF-15, MR proADM, and Presepsin) in 60 men under 65 who have acute coronary syndrome, pneumonia, and COPD, and have received an influenza vaccine. The goal is to see if these markers relate to the patients' health and how the vaccine affects them. Participants provide blood samples and medical history, but no new treatment is given.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
RSUD Dr. Saiful Anwar
RECRUITINGMalang, East Java, 65111, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.